查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1957813

2026年全球体细胞基因检测市场报告

Somatic Genetic Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体细胞基因检测市场发展迅速。预计该市场规模将从2025年的77.8亿美元成长到2026年的88.8亿美元，复合年增长率（CAGR）为14.1%。过去几年成长要素包括：基因检测普及率有限、对传统诊断方法的依赖、人们对癌症体细胞突变的认识不断提高、医院和临床实验室基础设施的扩建以及对研究机构投资的增加。

预计未来几年体细胞基因检测市场将快速成长，到2030年将达到149.2亿美元，复合年增长率（CAGR）为13.9%。预测期内的成长要素包括：次世代定序（NGS）和多体学技术的进步、家庭和临床定序服务的扩展、精准医疗倡议的推进、政府对基因检测计画的投入增加，以及基于人工智慧的突变解读分析技术的整合。预测期内的关键趋势包括：针对癌症和罕见疾病的标靶基因检测panel的广泛应用、次世代定序（NGS）技术的日益普及、个人化和精准癌症治疗的发展、家庭基因检测解决方案的扩展，以及多体学数据在临床决策中的应用。

癌症发生率的激增预计将推动体细胞基因检测市场的成长。癌症是一组疾病，其特征是异常细胞在体内不受控制地增生和扩散。这种成长趋势归因于营养不良、吸烟、缺乏运动和过度饮酒等生活方式因素。体细胞基因检测透过识别肿瘤特异性突变来辅助癌症诊断，从而实现精准的个人化治疗。它利用最尖端科技减少了侵入性检查，提高了检测的可靠性，并为患者提供了有益的结果。例如，加拿大癌症协会（总部位于加拿大的国家级癌症组织）在2023年11月预测，2023年将有239,100例新增癌症病例和约86,700例死亡病例。因此，癌症发生率的上升正在推动体细胞基因检测市场的发展。

体细胞基因检测市场的主要企业正在开发液态生物检体等诊断工具，以提高检测准确性、实现早期发现并避免侵入性手术。液态生物检体无需手术即可分析血液中的循环肿瘤DNA (ctDNA) 和生物标记物，从而检测癌症相关突变。例如，2024年9月，总部位于印度的基因组学和生物资讯学公司Strand Life Sciences推出了Somatic Advantage 74液态生物检体(SA74 LB) 检测，这是一种用于检测血液中ctDNA的先进液态生物检体技术。此检测采用次世代定序(NGS) 技术，分析74个关键癌基因中的体细胞突变。它无需组织取样即可识别可治疗的突变、追踪治疗效果并检测微量残存疾病(MRD)，从而实现个人化癌症治疗。该检测可用于标靶药物选择以及进展和抗药性的即时监测。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球体细胞基因检测市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 针对癌症和罕见疾病的标靶基因检测方法正在不断推广应用
    • 扩大次世代定序（NGS）技术的应用
    • 个人化和精准癌症治疗的发展
    • 家用基因检测解决方案的扩展
    • 整合多体学资料用于临床决策

第五章 终端用户产业市场分析

  • 医院
  • 临床检查室
  • 研究机构
  • 家庭检测服务提供者
  • 生物製药公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球体细胞基因检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球体细胞基因检测市场规模、对比及成长率分析
  • 全球体细胞基因检测市场表现：规模与成长，2020-2025年
  • 全球体细胞基因检测市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按类型
  • 标靶基因panel检测、全EXOME定序、全基因组定序及其他检测方法
  • 检体
  • 组织标本、血液标本、骨髓穿刺标本及其他检体
  • 透过技术
  • 聚合酵素链锁反应（PCR）、次世代定序（NGS）、微阵列、桑格定序及其他技术
  • 透过使用
  • 癌症诊断、心血管疾病、神经系统疾病及其他应用领域
  • 最终用户
  • 医院、临床检查室、研究机构和其他最终用户
  • 按类型细分：目标基因面板
  • 肿瘤科专家组、神经科专家组、心血管科专家组、罕见疾病专家组、药物基因学专家组
  • 按类型细分：全EXOME显子定序
  • 全EXOME定序用于诊断、全EXOME定序用于临床研究、基于人群的全EXOME定序
  • 按类型细分：全基因组定序
  • 临床全基因组定序、研究性全基因组定序、从头全基因组定序、癌症全基因组定序
  • 按类型细分：其他测试方法
  • 拷贝数变异检测、粒线体去氧核糖核酸（DNA）检测、核糖核酸（RNA）定序、表观遗传学检测

第十章 区域与国别分析

  • 全球体细胞基因检测市场：依地区划分，实际结果与预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球体细胞基因检测市场：依国家划分，实际结果与预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 体细胞基因检测市场：竞争格局及市场占有率（2024年）
  • 体细胞基因检测市场：公司估值矩阵
  • 体细胞基因检测市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Agilent Technologies Inc.

第37章 其他大型企业和创新企业

  • Illumina Inc., QIAGEN NV, Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年体细胞基因检测市场：提供新机会的国家
  • 2030年体细胞基因检测市场：新兴细分市场机会
  • 2030年体细胞基因检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH5MSGTE02_G26Q1

Somatic genetic testing involves the detailed analysis of genetic mutations that develop in non-reproductive (somatic) cells during a person's lifetime, most commonly in tumor tissues. This testing is essential in cancer diagnosis and treatment, as it identifies specific genetic alterations that can be targeted with personalized therapies, helping to predict disease progression and guide clinical decisions.

The main types of somatic genetic testing are targeted gene panels, whole exome sequencing, whole genome sequencing, carrier screening, and others. Targeted gene panels focus on analyzing a specific set of genes linked to a particular disease or condition, enabling precise and cost-effective diagnosis. Samples for testing include tissue-based, blood-based, bone marrow aspirates, and others, utilizing advanced technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and more. This testing is applied in cancer diagnosis, cardiovascular disorders, neurological disorders, inherited genetic disorders, and other areas, serving end users such as hospitals, clinical laboratories, research institutes, at-home testing providers, and more.

Tariffs have impacted the somatic genetic testing market by increasing costs of imported sequencing instruments, reagents, and consumables used in PCR, NGS, and microarray technologies. Segments like whole genome sequencing and targeted gene panels are most affected, particularly in North America and Europe, which rely heavily on imported high-tech equipment. This has resulted in higher operational costs and potential delays in testing services. On the positive side, tariffs have encouraged local manufacturing, investment in domestic sequencing infrastructure, and development of cost-efficient testing solutions.

The somatic genetic testing market research report is one of a series of new reports from The Business Research Company that provides somatic genetic testing market statistics, including somatic genetic testing industry global market size, regional shares, competitors with a somatic genetic testing market share, detailed somatic genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the somatic genetic testing industry. This somatic genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The somatic genetic testing market size has grown rapidly in recent years. It will grow from $7.78 billion in 2025 to $8.88 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to limited access to genetic testing, reliance on conventional diagnostic methods, growing awareness of somatic mutations in cancer, increasing hospital and clinical laboratory infrastructure, rising investment in research institutes.

The somatic genetic testing market size is expected to see rapid growth in the next few years. It will grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in ngs and multi-omics technologies, expansion of at-home and clinical sequencing services, increasing precision medicine initiatives, rising government funding for genetic testing programs, integration of ai-based analytics for mutation interpretation. Major trends in the forecast period include rising adoption of targeted gene panels for cancer and rare diseases, increasing use of next-generation sequencing (ngs) technologies, growth in personalized and precision oncology treatments, expansion of at-home genetic testing solutions, integration of multi-omics data for clinical decision-making.

The escalating cancer incidence is poised to drive the somatic genetic testing market forward. Cancer encompasses disorders defined by rampant, spreading abnormal cells throughout the body. This growing burden stems from lifestyle factors like suboptimal nutrition, tobacco use, lack of exercise, and heavy drinking. Somatic genetic testing supports cancer diagnosis by pinpointing tumor-specific mutations, facilitating precise, individualized therapies. It curbs invasive methods through cutting-edge tools, enhancing detection reliability and patient results. For example, in November 2023, the Canadian Cancer Society, a Canada-based national cancer organization, projected 239,100 new diagnoses and about 86,700 deaths in 2023. Thus, the rising cancer incidence is fueling the somatic genetic testing market.

Prominent companies in the somatic genetic testing market are advancing diagnostic tools like liquid biopsy tests to sharpen precision, enable early spotting, and sidestep invasive steps. Liquid biopsy tests offer non-surgical analysis of circulating tumor DNA (ctDNA) or biomarkers in blood to uncover cancer-linked mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics firm, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a state-of-the-art liquid biopsy for ctDNA detection from blood. This NGS-driven assay scans somatic alterations in 74 critical cancer genes. It empowers tailored oncology by flagging treatable mutations, tracking therapy effects, and spotting minimal residual disease (MRD) minus tissue sampling. The test guides targeted drugs and real-time progression or resistance surveillance.

In June 2023, Genomenon Inc., a US healthcare tech company, acquired Boston Genetics Inc. for an undisclosed sum. This merger amplifies Genomenon's goal to map the full human genome by fusing its AI-driven Mastermind platform with Boston Genetics' expert team, elevating genomic analysis for clinical testing and drug development. Boston Genetics Inc. is a US genomics firm expert in variant curation and annotation via specialist geneticists.

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the somatic genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The somatic genetic testing market consists of revenues earned by entities by providing services such as tumor profiling, biomarker identification, companion diagnostic testing, mutation analysis, and next-generation sequencing (NGS) for personalized cancer therapy selection and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The somatic genetic testing market also includes sales of testing kits, reagents, assay panels, sequencing instruments, software tools for data analysis, and laboratory consumables used in the detection and interpretation of somatic mutations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Somatic Genetic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses somatic genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for somatic genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The somatic genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Targeted Gene Panels; Whole Exome Sequencing; Whole Genome Sequencing; Other Testing Methods
  • 2) By Sample: Tissue-Based; Blood-Based; Bone Marrow Aspirates; Other Samples
  • 3) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Microarray; Sanger Sequencing; Other Technologies
  • 4) By Application: Cancer Diagnosis; Cardiovascular Disorders; Neurological Disorders; Other Applications
  • 5) By End-User: Hospitals; Clinical Laboratories; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Targeted Gene Panels: Oncology Panels; Neurology Panels; Cardiovascular Panels; Rare Disease Panels; Pharmacogenomics Panels
  • 2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing; Clinical Research Whole Exome Sequencing; Population-Based Whole Exome Sequencing
  • 3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; De Novo Whole Genome Sequencing; Cancer Whole Genome Sequencing
  • 4) By Other Testing Methods: Copy Number Variation Testing; Mitochondrial Deoxyribonucleic Acid (DNA) Testing; Ribonucleic Acid (RNA) Sequencing; Epigenetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Exact Sciences Corp.; ARUP Laboratories Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; MedGenome Labs Ltd.; Caris Life Sciences Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Invivoscribe Inc.; Centogene N.V.; Circulogene Theranostics LLC.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Somatic Genetic Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Somatic Genetic Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Somatic Genetic Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Somatic Genetic Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Targeted Gene Panels For Cancer And Rare Diseases
    • 4.2.2 Increasing Use Of Next-Generation Sequencing (NGS) Technologies
    • 4.2.3 Growth In Personalized And Precision Oncology Treatments
    • 4.2.4 Expansion Of At-Home Genetic Testing Solutions
    • 4.2.5 Integration Of Multi-Omics Data For Clinical Decision-Making

5. Somatic Genetic Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Laboratories
  • 5.3 Research Institutes
  • 5.4 At-Home Testing Providers
  • 5.5 Biopharmaceutical Companies

6. Somatic Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Somatic Genetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Somatic Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Somatic Genetic Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Somatic Genetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Somatic Genetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Somatic Genetic Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Somatic Genetic Testing Market Segmentation

  • 9.1. Global Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods
  • 9.2. Global Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples
  • 9.3. Global Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies
  • 9.4. Global Somatic Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications
  • 9.5. Global Somatic Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinical Laboratories, Research Institutes, Other End-Users
  • 9.6. Global Somatic Genetic Testing Market, Sub-Segmentation Of Targeted Gene Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels
  • 9.7. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing
  • 9.8. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing
  • 9.9. Global Somatic Genetic Testing Market, Sub-Segmentation Of Other Testing Methods, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

10. Somatic Genetic Testing Market Regional And Country Analysis

  • 10.1. Global Somatic Genetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Somatic Genetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Somatic Genetic Testing Market

  • 11.1. Asia-Pacific Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Somatic Genetic Testing Market

  • 12.1. China Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Somatic Genetic Testing Market

  • 13.1. India Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Somatic Genetic Testing Market

  • 14.1. Japan Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Somatic Genetic Testing Market

  • 15.1. Australia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Somatic Genetic Testing Market

  • 16.1. Indonesia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Somatic Genetic Testing Market

  • 17.1. South Korea Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Somatic Genetic Testing Market

  • 18.1. Taiwan Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Somatic Genetic Testing Market

  • 19.1. South East Asia Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Somatic Genetic Testing Market

  • 20.1. Western Europe Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Somatic Genetic Testing Market

  • 21.1. UK Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Somatic Genetic Testing Market

  • 22.1. Germany Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Somatic Genetic Testing Market

  • 23.1. France Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Somatic Genetic Testing Market

  • 24.1. Italy Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Somatic Genetic Testing Market

  • 25.1. Spain Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Somatic Genetic Testing Market

  • 26.1. Eastern Europe Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Somatic Genetic Testing Market

  • 27.1. Russia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Somatic Genetic Testing Market

  • 28.1. North America Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Somatic Genetic Testing Market

  • 29.1. USA Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Somatic Genetic Testing Market

  • 30.1. Canada Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Somatic Genetic Testing Market

  • 31.1. South America Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Somatic Genetic Testing Market

  • 32.1. Brazil Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Somatic Genetic Testing Market

  • 33.1. Middle East Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Somatic Genetic Testing Market

  • 34.1. Africa Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Somatic Genetic Testing Market Regulatory and Investment Landscape

36. Somatic Genetic Testing Market Competitive Landscape And Company Profiles

  • 36.1. Somatic Genetic Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Somatic Genetic Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Somatic Genetic Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Somatic Genetic Testing Market Other Major And Innovative Companies

  • Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc.

38. Global Somatic Genetic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Somatic Genetic Testing Market

40. Somatic Genetic Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Somatic Genetic Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Somatic Genetic Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Somatic Genetic Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer